Computational drug repositioning for cancer therapeutics

Mingkun Jiao, Gang Liu, Yu Xue, Chunyong Ding

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Due to ever-increasing failure rates, high cost, unsatisfactory safety profile, and limited efficacy associated with anticancer drug development, the repositioning of established non-cancer drugs for new oncology indications has emerged as an increasingly attractive approach to addressing the unmet cancer-related medical need. With the rapid development of bioinformatics, chemoinformatics as well as high-performance computing, drug repositioning is becoming more intentional than ever, and a significant surge of computational approaches has been well established to greatly facilitate drug repositioning for cancer treatment. In this review, we provide a brief overview of recent advances in the computational drug repositioning for anticancer applications with a specific emphasis on repositioning of non-cancer drugs by use of various computational approaches.

Original languageEnglish (US)
Pages (from-to)767-775
Number of pages9
JournalCurrent topics in medicinal chemistry
Issue number8
StatePublished - 2015
Externally publishedYes


  • Anticancer drugs
  • Cancer therapeutics
  • Computational drug repositioning
  • Drug discovery
  • Drug repositioning
  • Drug repurposing

ASJC Scopus subject areas

  • Drug Discovery


Dive into the research topics of 'Computational drug repositioning for cancer therapeutics'. Together they form a unique fingerprint.

Cite this